Baird’s DexCom DXCM Stock Holding History

Baird’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1.76M	Sell	113,280 -4,040	-3%	-$61K	0.02%	577
2014 Q4	$1.61M	Buy	+117,320	New	+$1.44M	0.02%	594
2014 Q2	–	Sell	-134,080	Closed	-$1.39M	–	1159
2014 Q1	$1.39M	Buy	134,080 +67,680	+102%	+$700K	0.02%	549
2013 Q4	$588K	Buy	+66,400	New	+$525K	0.01%	779

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Baird's DXCM Position: Q1 2015 in Review

Baird reduced its DexCom (DXCM) stake by 3.4% in Q1 2015, selling an estimated $61K and leaving 113,280 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #577.

Baird first reported a position in DXCM in Q4 2013 and has held it in 4 quarters since. 245 funds tracked by Wall St. Rank hold DXCM as of Q1 2015.

Baird held 113,280 shares of DexCom worth $1.76M as of Q1 2015.
Baird sold 4,040 DexCom shares in Q1 2015, an estimated $61K.
DexCom made up 0.02% of Baird's portfolio in Q1 2015, its #577 holding.
Baird first reported a position in DexCom in Q4 2013 and has held it in 4 quarters since.
245 funds tracked by Wall St. Rank held DexCom as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.